Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor

Transplantation

Volumn 62, Issue 4, 1996, Pages 497-502

  Lurain, Nell S ^a   Ammons, Harryl C ^a   Kapell, Kathi S ^a   Yeldandi, Vijay V ^b   Garrity, E R ^b   Paul O'Keefe, J ^b  

^a RUSH UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LUNG TRANSPLANTATION; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS DETECTION;

EID: 0029843175     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608270-00012     Document Type: Article

References (30)

1. Bailey TC, Buller RS, Ettinger, NA, et al. Quantitative analysis of cytomegalovirus viremia in lung transplant recipients. J Infect Dis 1995; 171: 1006.
2. Duncan SR, Grgurich WF, Iacono AT, et al. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 1994; 150: 146.
3. Grossi P, Minoli L, Percivalle E, Irish W, Vigano M, Gerna G. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation 1995; 59: 847.
4. Paya CV, Marin E, Keating M, Dickson R, Porayko M, Wiesner, R. Solid organ transplantation: results and implications of acyclovir use in liver transplants. J Med Virol (suppl) 1993; 1: 123.
5. Kelly JL, Albert RK, Wood DE, Raghu G. Efficacy of a 6-week prophylactic ganciclovir regimen and the role of serial cytomegalovirus antibody testing in lung transplant recipients. Transplantation 1995; 59: 1144.
6. Smyth RL, Scott JP, Borysiewicz LK, et al. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis 1991; 164: 1045.
7. Cooper JD, Patterson GA, Trulock EP, et al. Results of single and bilateral lung transplantation in 131 consecutive recipients. J Thorac Cardiovasc Surg 1994; 107: 460.
8. Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus infection and pneumonitis. Am Rev Respir Dis 1993; 147: 1017.
9. Montoya A, Mawulawde K, Houck J, et al. Survival and functional outcome after single and bilateral lung transplantation. Surgery 1994; 116: 712.
10. Wreghitt T. Cytomegalovirus infections in heart and heart-lung transplant recipients. J Antimicrob Chemother 1989; 23(suppl E): 49.
11. Pollock JL, Virgin HW. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol 1995; 69: 1762.
12. Sinzger C, Grefte A, Plachter B, Gouw ASH, The TH, Jahn G. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995; 76: 741.
13. Chou S, Erice A, Jordan MC, et al. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 1995; 171: 576.
14. Wolf, DG, Lee DJ, Spector SA. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 1995; 39: 2552.
15. Bailey TC, Trulock EP, Ettinger NA, Storch GA, Cooper JD, Powderly WG. Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. J Infect Dis 1992; 165: 548.
16. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 1992; 358: 162.
17. Lurain NS, Thompson KD, Holmes EW, Read GS. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol 1992; 66: 7146.
18. Lurain NS, Spafford LE, Thompson KD. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J Virol 1994; 68: 4427.
19. Tatarowicz WA, Lurain NS, Thompson KD. A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J Infect Dis 1992; 166: 904.
20. Shigeta S, Konno K, Baba M, Yokota T, DeClercq E. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. J Infect Dis 1991; 163: 270.
21. Eizuru Y, Inagawa S, Minamishima Y. Application of "Hirt supernatant" DNA to the molecular epidemiology of cytomegalovirus infections. J Clin Microbiol 1984; 20: 1012.
22. Fleckenstein B, Muller I, Collins J Cloning of the complete human cytomegalovirus genome in cosmids. Gene 1982; 18: 39.
23. Stanat SC, Reardon JE, Erice A, Jordan MC, Drew WL, Biron KK. Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother 1991; 35: 2191.
24. Baldanti F, Silini E, Sarasini A, et al. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 1995; 69: 796.
25. Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A. Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother 1995; 39: 1204.
26. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomeglovirus isolates. J Infect Dis 1995; 172: 239.
27. Wolf DG, Smith IL, Lee DJ, Freeman WR, Flores-Aguilar M, Spector SA. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest 1995; 95: 257.
28. Baldanti F, Underwood MR, Stanat SC, et al. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J Virol 1996; 70: 1390.
29. Chou S. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N Engl J Med 1986; 314: 1418.
30. Grundy JE, Lui SF, Super M, et al. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 1988; 2: 132.